Press Releases

STOCKHOLM, Jan. 7, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company has exclusively inlicensed a VR1 project, which is in clinica

ATLANTA, Jan. 7, 2020 /PRNewswire/ -- Quality Executive Partners, Inc. (QxP) is honored to recognize the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) for their support during development of Virtuosi®, an on-demand educational platform that leverages the power of virtual reality (VR). 

BREA, Calif., Jan. 7, 2020 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 haematology analysers and the Early Sepsis Indicator across the SWLP network.

STOCKHOLM, Jan. 7, 2020 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative solutions for neurocritical care, today provides an update on the launch of its products in the United States (US) and product portfolio objectives for 2020.  "We are excited to report on the growth and

STOCKHOLM, Jan. 7, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Karin Eklund Vanderpol has been appointed as head of regulatory affairs of Oncopeptides. Karin has 20 years of experience from senior positions in regulatory affairs. Prior to joining Oncopeptides, she served as Global Regulatory Directo

STOCKHOLM, Jan. 7, 2020 /PRNewswire/ -- SCA's Christmas gift to the company's employees in 2019 was a donation of SEK 1.5 MSEK to three recipients. Cancer Research Foundation Northern Sweden received the largest donation.SCA's employees decided how the donation was to be divided between the three recipients by voting for the th

SINGAPORE, Jan. 6, 2020 /PRNewswire/ -- Mundipharma has announced today that it has sealed an exclusive sales agreement with Biosolution Co., Ltd, a Korea-based leader in cell-based biotechnology, to market and distribute its fourth-generation autologous chondrocyte implantation product, CartiLife®.

LAS VEGAS, Jan. 6, 2020 /PRNewswire/ -- WHO:

HOFFMAN ESTATES, Ill., Jan. 6, 2020 /PRNewswire/ -- Global technology leader OMRON Corporation is showcasing the largest range of its technology at the 2020 Consumer Electronics Show (CES), including exhibits of factory automation, social solutions, and healthcare, and showing how the company is developing new offerings to address future issues. Emphasizing th

SHANGHAI, Jan. 6, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced that the company has entered into a clinical collaboration with a subsidiary of Merck & Co, Inc.